ALDA & Associates International, Inc. Newsletter
March/April 2018
Representative Engagements
- Initiated and developed a de novo Accountable Care Organization to participate in the Medicare Shared Savings Program which grew to over 250 physicians over three years which successfully generated savings.
- Financial advisor to large physician practice in connection with a potential acquisition transaction where engagement includes determination of strategic and fair value and assisting in negotiations for closing the acquisition and in post acquisition integration.
- Review and in-depth analysis of new Medicare Reimbursement rules for subsidiary of Fortune 50 insurance company and assistance in developing a business model enabling the capture of a new revenue stream for both physician practices and affiliated providers.
- Acquisition due diligence and integration assistance for a public healthcare staffing company involved in numerous acquisitions. Retained by parent company to manage acquired company for 22 weeks through ALDA developed integration plan.
- Turnaround assistance for a near bankrupt client company, including tax and financial restructuring, and ultimate sale at a significant cash price.
- Leadership of development of client company's strategic plan for the next decade and assistance in repositioning the company.
- Determination of strategic value of a client company, packaging for sale and assisting in negotiations.
- Providing the entire management team for several life science and healthcare companies from early stage through obtaining additional patent protection, guiding clinical development plans, navigating the pathway through the FDA, establishing the manufacturing processes, initiating commercial sales and eventually transforming the Company into a publicly traded Company.
- Determination of strategic implications of a line of business with weak performance; development of strategies to maximize profitability contribution.
- Turnaround assistance for a troubled venture-backed company, including raising additional debt and equity capital.
- Acquisition and financing assistance for a public, international railroad in connection with a $300 million cross-border acquisition and refinancing.
Our experienced professionals are dedicated to helping clients unlock inherent value and create new value.
The ALDA Team includes, among others:
David H. Fater - Chief Executive Officer
Strategy, capital markets, restructuring, and mergers and acquisitions experience with public healthcare companies focused on physician management, rural healthcare, nursing homes, HMO's, diagnostic imaging and medical devices. Deeply involved in the implementation of the Affordable Care Act with Accountable Care Organizations, Independent Practice Associations and Management Services Organizations.
Richard M. Cohen - Senior Operations and Business Development Executive
Healthcare operations and worldwide sourcing experience. Skilled in healthcare (physician management, clinical trials, medical and patient process flow, diagnostic imaging and life science) operations as well as in issues dealing with importing, exporting and manufacturing operations in South America, Far East and Europe.
Thomas J. Bohannon - Senior Financial Executive
Accomplished, creative CPA, outstanding analytical and technical abilities. Has experience for over 40 years in public accounting and private industry including nursing homes, medical device companies, hospitals, not-for-profits, retail, manufacturing, import/export and natural resources.
A. Ronald Turner - Senior Healthcare Executive
Senior healthcare industry executive with strong entrepreneurial focus including CEO and COO positions with start-up hospital companies and a publicly-traded hospital company. Extensive and successful operations experience for more than 50 hospitals and 9 nursing homes, and senior reimbursement experience for a major publicly-traded hospital company and a national accounting firm. Experienced in mergers and acquisitions, led operational turnarounds and debt restructurings that created significant value.
Mark W. Caton – Senior Healthcare Executive
Senior hospital executive with over 30 years experience in operating not-for-profit and investor-owned rural/community hospitals as CEO or COO, and Regional COO with several national hospital companies. Skilled in strategic planning and business development, operations management, revenue cycle management, medical staff development, and quality/resource management.
Daniel N. Weiss, M.D., F.A.C.C. - Chief Medical Officer
Medical devices and healthcare practice experience, engaged in a private medical electrophysiology practice where he performs numerous invasive cardiac procedures and has served as a consultant for several Fortune 500 Medical Device Companies including Philips, Boston Scientific/Guidant, St. Jude and Medtronic, as well as for several medical device and drug start-up companies.
David Bott - Senior Information Technology Executive
Systems and network support solutions experience, proviedes analyis of strategic business needs and assessment of business models and their integration with technology.
Jeffrey E. Topfer, JD, MPH - Senior Operations Executive
Healthcare operations and technology experience, provides business development and mergers and acquisitions services, merger integration implementation, legal transaction advice, due diligence assistance, strategic planning, development of innovative business concepts and operational processes.
David E. Huizenga, Ph.D., JD - Senior Scientist and Patent Attorney
Patent portfolio management, licensing, and competitive intelligence. Provides translation of a company’s science strategy to the patent and business strategy.
Santiago Guzman - International Executive
Experienced in new project development for companies in a variety of industries from start-up to Fortune 500. Client relations management, fluent in English and Spanish. Skilled facilitator for introductions with influential leaders in South America including those in the health care industry.
Jerry M. Anchin, Ph.D - Drug Discovery, Device and Diagnostics Executive
Extensive experience in biotechnology research and business ventures having been actively involved in the fields of immunology, molecular biology, drug discovery, and protein chemistry since 1978 and has experience as the Head of Assay Development and Manufacturing and Group leader of Drug Discovery.
With offices in:
- Delray Beach/Boca Raton, FL
- Atlanta
- New York
- Quito, Ecuador
For additional information, please contact:
David H. Fater, Chief Executive Officer
ALDA & Associates International, Inc.
751 Park of Commerce Drive; Suite 128
Boca Raton, FL 33487
(877) 845-4657